A Food and Drug Administration advisory committee last week recommendedapproval of Merck's Fosamax drug for the treatment of osteoporosis.If Fosamax is approved by the FDA, it is expected to give a boostto vendors of dual-energy x-ray absorptiometry
A Food and Drug Administration advisory committee last week recommendedapproval of Merck's Fosamax drug for the treatment of osteoporosis.If Fosamax is approved by the FDA, it is expected to give a boostto vendors of dual-energy x-ray absorptiometry (DEXA) scanners,such as Lunar and Hologic. Merck last month announced financingagreements with the companies to help promote sales of bone densitometrydevices (SCAN 7/6/95).
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.